Plunkett Research Online: Abivax

ABIVAX (AAVXF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Abivax SA is a France based biotechnology company. It is focused on using antiviral technology platform targeting the immune system to eliminate viral diseases. The company's product is ABX 464 which is for treating HIV/AIDS. The antiviral and immunotherapeutic products that the group develops resul.....



Abivax
Ticker: AAVXF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 153830841
Fax:
Address: 5, rue de la Baume
Paris, 75008 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Abivax SA is a France based biotechnology company. It is focused on using antiviral technology platform targeting the immune system to eliminate viral diseases. The company's product is ABX 464 which is for treating HIV/AIDS. The antiviral and immunotherapeutic products that the group develops resul.....See More See More

Auditor: PricewaterhouseCoopers Audit SA
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: